The role of lineage plasticity in prostate cancer therapy resistance-Reference-Cited by-同舟云学术

The role of lineage plasticity in prostate cancer therapy resistance

Published:2019-07-30 Issue: Volume: Page:clincanres.1423.2019
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Beltran Himisha,Hruszkewycz Andrew,Scher Howard I.,Hildesheim Jeffrey,Isaacs Jennifer,Yu Evan Y,Kelly Kathleen,Lin Daniel,Dicker Adam P.,Arnold Julia T^ORCID,Hecht Toby T.,Wicha Max S.,Sears Rosalie C.,Rowley David R.,White Richard M.^ORCID,Gulley James L^ORCID,Lee John K,Diaz-Meco Maria T,Small Eric J.,Shen Michael M.^ORCID,Knudsen Karen E,Goodrich David W^ORCID,Lotan Tamara L.,Zoubeidi Amina,Sawyers Charles L,Rudin Charles M.^ORCID,Loda Massimo,Thompson Timothy C.,Rubin Mark A.^ORCID,Tawab-Amiri Abdul,Dahut William,Nelson Peter S.

Funder

HHS | NIH | National Cancer Institute (NCI)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary Well-Differentiated Neuroendocrine Tumor/Carcinoid of the Prostate: Case Report and Review of Literature;International Journal of Surgical Pathology;2024-02-01

2. LSD1 inhibition suppresses ASCL1 and de-represses YAP1 to drive potent activity against neuroendocrine prostate cancer;2024-01-22

3. Diagnosis and management of neuroendocrine prostate cancer;The Prostate;2024-01-03

4. Metabolic switch regulates lineage plasticity and induces synthetic lethality in triple-negative breast cancer;Cell Metabolism;2024-01

5. Exploiting the DNA Damage Response for Prostate Cancer Therapy;Cancers;2023-12-23